Behavioural and Psychological Symptoms of Dementia and Their Management in Care Homes Within the East of England: a Postal Survey
Overview
Affiliations
Objectives: To determine the prevalence of antipsychotic use in care homes. To explore which behaviours care home staff can find difficult to manage and which non-pharmacological interventions are currently used within care homes to help cope with behavioural and psychological symptoms of dementia.
Method: A postal survey sent to all care homes registered as specialising in the care of older people or/and older people with dementia within four counties in the East of England (n = 747).
Results: Questionnaires were returned from 299 care home managers (40%). The vast majority (n = 200, 73%) reported having at least one resident with an antipsychotic prescription in their home. Twelve percent (n = 1027) of care home residents were reported to be prescribed antipsychotic medications. Aggression was most frequently reported, by 37% (n = 109) of care home managers, as a difficult behaviour to manage. Non-pharmacological interventions were reported to be used in 87% (n = 253) of care homes. The interventions most commonly used in care homes to manage difficult behaviours were reminiscence (75%, n = 219) and music therapy (73%, n = 213).
Conclusion: This survey was a first attempt to estimate the use of antipsychotics in care homes. Despite measures to reduce antipsychotic use for all people with dementia in England, we found that 12% of care home residents were still prescribed antipsychotic medication. Around half of all care home managers reported they had experienced behaviours they found difficult. Antipsychotic medications and a variety of non-pharmacological interventions appear to be used concurrently in many care homes.
Raza A, Piekarz H, Jawad S, Langran T, Donyai P Int J Clin Pharm. 2023; 45(5):1050-1061.
PMID: 37773304 PMC: 10600045. DOI: 10.1007/s11096-023-01645-2.
Differential Association of Aggression With Sadness for People With Moderate and Severe Dementia.
ORourke H, Fraser K, Duggleby W Am J Alzheimers Dis Other Demen. 2020; 35:1533317520939781.
PMID: 32666818 PMC: 10623928. DOI: 10.1177/1533317520939781.
Griffiths A, Surr C, Alldred D, Baker J, Higham R, Spilsbury K Int J Clin Pharm. 2019; 41(5):1314-1322.
PMID: 31342248 PMC: 6800850. DOI: 10.1007/s11096-019-00883-7.
Szczepura A, Wild D, Khan A, Owen D, Palmer T, Muhammad T BMJ Open. 2016; 6(9):e009882.
PMID: 27650756 PMC: 5051335. DOI: 10.1136/bmjopen-2015-009882.